重温新辅助化疗在西斯普拉丁合格的肌肉侵入性膀癌的治疗
Javier Molina-Cerrillo1, James Catto2, Ashish M Kamat3
1Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
European urology oncology
|October 9, 2025
概括
新辅助化疗免疫疗法是肌肉侵入性膀癌 (MIBC) 的新选择. 生物标志物和新药的进步正在个性化MIBC治疗,以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 尿癌研究 尿癌研究
- 癌症治疗策略 癌症治疗策略
背景情况:
- 肌肉侵入性膀癌 (MIBC) 管理正在迅速发展.
- 基于西斯的新辅助化疗是符合条件的患者的标准,改善了生存率.
- 最近像NIAGARA这样的试验正在完善治疗方案.
研究的目的:
- 审查MIBC的现有和新兴的新辅助策略.
- 概述 MIBC 个性化治疗的未来方向.
- 总结系统疗法和MIBC分子理解方面的进展.
主要方法:
- 对最近的研究和临床试验数据的文献综述.
- 对新辅助化疗,免疫疗法和组合疗法进行了集中审查.
- 检查新药,生物标志物驱动的方法和膀保护策略.
主要成果:
- 新辅助化疗免疫疗法 (杜尔瓦卢马布加化疗) 显示出显著的生存和反应益处.
- 生物标志物 (例如ctDNA,DDR突变) 和抗体-药物结合物正在推动个性化治疗.
- 选择最佳治疗方案和响应评估方法需要进一步的研究.
结论:
- 免疫疗法整合和生物标志物策略正在改变新辅助MIBC护理.
- 治疗正在转向基于生物标志物的风险调整方法.
- 个性化,基于精度的护理需要精细的患者选择和治疗顺序.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.7K
08:43An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
15.2K
相关概念视频
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
599
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
599
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
583
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
583